Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2023

Open Access 01-12-2023 | Myasthenia Gravis | Research

Analysis of influencing factors of perioperative myasthenic crisis in 387 myasthenia gravis patients without thymoma in a single center

Authors: Peng Jiao, Fanjuan Wu, Yuxing Liu, Jiangyu Wu, Yaoguang Sun, Wenxin Tian, Hanbo Yu, Chuan Huang, Donghang Li, Qingjun Wu, Chao Ma, Hongfeng Tong

Published in: Journal of Cardiothoracic Surgery | Issue 1/2023

Login to get access

Abstract

Objective

To study the influencing factors of myasthenic crisis in non-thymoma myasthenia gravis (MG) patients during perioperative period.

Methods

We retrospectively analyzed a total of 387 non-thymoma MG patients who underwent extended thymoma resection in the Department of Thoracic Surgery of Beijing Hospital from February 2011 to December 2021, recorded ASA score, Osserman classification, preoperative course, pyridostigmine dosage, operation method, operation time, and intraoperative blood loss, then analyzed the factors associated with postoperative myasthenic crisis by univariate and multivariate logistic regression.

Results

Osserman classification IIB + III + IV (P < 0.001), history of myasthenic crisis (P = 0.013), pyridostigmine dosage greater than 240 (P < 0.001), ASA score 2 and 3 (P = 0.001) are independent risk factors for myasthenic crisis.

Conclusion

Patients with poor Osserman classification, history of myasthenic crisis before surgery, larger preoperative dosage of pyridostigmine, and higher ASA scores should be highly alert to the occurrence of postoperative myasthenic crisis.
Literature
1.
go back to reference Hughes T. The early history of myasthenia gravis. Neuromuscul Disord. 2005;15(12):878–86.CrossRef Hughes T. The early history of myasthenia gravis. Neuromuscul Disord. 2005;15(12):878–86.CrossRef
2.
go back to reference Zieliński M. Surgical approaches to myasthenia gravis: perspective of anatomy and radicality in surgery. Thorac Surg Clin. 2019;29(2):159–64.CrossRef Zieliński M. Surgical approaches to myasthenia gravis: perspective of anatomy and radicality in surgery. Thorac Surg Clin. 2019;29(2):159–64.CrossRef
3.
go back to reference Wolfe GI, et al. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med. 2016;375(6):511–22.CrossRef Wolfe GI, et al. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med. 2016;375(6):511–22.CrossRef
4.
go back to reference Carr AS, et al. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010;10:46.CrossRef Carr AS, et al. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010;10:46.CrossRef
5.
go back to reference Liu C, et al. Assessment of the risks of a myasthenic crisis after thymectomy in patients with myasthenia gravis: a systematic review and meta-analysis of 25 studies. J Cardiothorac Surg. 2020;15(1):270.CrossRef Liu C, et al. Assessment of the risks of a myasthenic crisis after thymectomy in patients with myasthenia gravis: a systematic review and meta-analysis of 25 studies. J Cardiothorac Surg. 2020;15(1):270.CrossRef
6.
go back to reference Howard JF Jr, et al. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017;16(12):976–86.CrossRef Howard JF Jr, et al. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017;16(12):976–86.CrossRef
7.
go back to reference Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87(4):419–25.CrossRef Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87(4):419–25.CrossRef
8.
go back to reference Sonett JR, Jaretzki A 3rd. Thymectomy for nonthymomatous myasthenia gravis: a critical analysis. Ann N Y Acad Sci. 2008;1132:315–28.CrossRef Sonett JR, Jaretzki A 3rd. Thymectomy for nonthymomatous myasthenia gravis: a critical analysis. Ann N Y Acad Sci. 2008;1132:315–28.CrossRef
9.
go back to reference Xue L, et al. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis. Eur J Cardiothorac Surg. 2017;52(4):692–7.CrossRef Xue L, et al. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis. Eur J Cardiothorac Surg. 2017;52(4):692–7.CrossRef
10.
go back to reference Niu YD, Wang TS, Zhao S, Ding LX. Predictors of early postoperative crisis for myasthenia gravis. Chin J Gerontol. 2013;33:2362–4. Niu YD, Wang TS, Zhao S, Ding LX. Predictors of early postoperative crisis for myasthenia gravis. Chin J Gerontol. 2013;33:2362–4.
11.
go back to reference Chu XY, et al. Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy. Chin Med J. 2011;124(8):1246–50. Chu XY, et al. Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy. Chin Med J. 2011;124(8):1246–50.
12.
go back to reference Akaishi T, et al. Preoperative risks of post-operative myasthenic crisis (POMC): a meta-analysis. J Neurol Sci. 2019;407:116530.CrossRef Akaishi T, et al. Preoperative risks of post-operative myasthenic crisis (POMC): a meta-analysis. J Neurol Sci. 2019;407:116530.CrossRef
13.
go back to reference Lucchi M, et al. Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment. Eur J Cardiothorac Surg. 2009;35(5):812–6.CrossRef Lucchi M, et al. Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment. Eur J Cardiothorac Surg. 2009;35(5):812–6.CrossRef
14.
go back to reference Putman MT, Wise RA. Myasthenia gravis and upper airway obstruction. Chest. 1996;109(2):400–4.CrossRef Putman MT, Wise RA. Myasthenia gravis and upper airway obstruction. Chest. 1996;109(2):400–4.CrossRef
15.
go back to reference Nam TS, et al. Clinical characteristics and predictive factors of myasthenic crisis after thymectomy. J Clin Neurosci. 2011;18(9):1185–8.CrossRef Nam TS, et al. Clinical characteristics and predictive factors of myasthenic crisis after thymectomy. J Clin Neurosci. 2011;18(9):1185–8.CrossRef
16.
go back to reference Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281–4.CrossRef Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281–4.CrossRef
17.
go back to reference Liu Y, et al. Relationship between American Society of Anesthesiologists (ASA) grade and 1-year mortality in nonagenarians undergoing hip fracture surgery. Osteoporos Int. 2015;26(3):1029–33.CrossRef Liu Y, et al. Relationship between American Society of Anesthesiologists (ASA) grade and 1-year mortality in nonagenarians undergoing hip fracture surgery. Osteoporos Int. 2015;26(3):1029–33.CrossRef
18.
go back to reference Sankar A, et al. Reliability of the American Society of Anesthesiologists physical status scale in clinical practice. Br J Anaesth. 2014;113(3):424–32.CrossRef Sankar A, et al. Reliability of the American Society of Anesthesiologists physical status scale in clinical practice. Br J Anaesth. 2014;113(3):424–32.CrossRef
19.
go back to reference Giannice R, et al. Perioperative morbidity and mortality in elderly gynecological oncological patients (>/= 70 Years) by the American Society of Anesthesiologists physical status classes. Ann Surg Oncol. 2004;11(2):219–25.CrossRef Giannice R, et al. Perioperative morbidity and mortality in elderly gynecological oncological patients (>/= 70 Years) by the American Society of Anesthesiologists physical status classes. Ann Surg Oncol. 2004;11(2):219–25.CrossRef
20.
go back to reference Mayhew D, Mendonca V, Murthy BVS. A review of ASA physical status - historical perspectives and modern developments. Anaesthesia. 2019;74(3):373–9.CrossRef Mayhew D, Mendonca V, Murthy BVS. A review of ASA physical status - historical perspectives and modern developments. Anaesthesia. 2019;74(3):373–9.CrossRef
21.
go back to reference Jensen P, Bril V. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis. J Clin Neuromuscul Dis. 2008;9(3):352–5.CrossRef Jensen P, Bril V. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis. J Clin Neuromuscul Dis. 2008;9(3):352–5.CrossRef
22.
go back to reference Gamez J, et al. Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis. Ther Adv Neurol Disord. 2019;12:1756286419864497.CrossRef Gamez J, et al. Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis. Ther Adv Neurol Disord. 2019;12:1756286419864497.CrossRef
Metadata
Title
Analysis of influencing factors of perioperative myasthenic crisis in 387 myasthenia gravis patients without thymoma in a single center
Authors
Peng Jiao
Fanjuan Wu
Yuxing Liu
Jiangyu Wu
Yaoguang Sun
Wenxin Tian
Hanbo Yu
Chuan Huang
Donghang Li
Qingjun Wu
Chao Ma
Hongfeng Tong
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2023
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-023-02136-1

Other articles of this Issue 1/2023

Journal of Cardiothoracic Surgery 1/2023 Go to the issue